VJHemOnc is committed to improving our service to you

IMW 2019 | Updated FDA MRD guidelines for hematological malignancies

VJHemOnc is committed to improving our service to you

Nicole Gormley

Nicole Gormley, MD, FDA, Silver Spring, MD, discusses the updated measurable residual disease (MRD) guidlines being produced by the FDA at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter